Recombinant CD19 (Inebilizumab Biosimilar) anticorps

N° du produit ABIN7581284

Cet anticorps anti-CD19 (Inebilizumab Biosimilar) est un anticorps Human Monoclonal détectant CD19 (Inebilizumab Biosimilar) dans ELISA, FACS, BLI, Func et SPR. Adapté pour Humain.

Aperçu rapide pour Recombinant CD19 (Inebilizumab Biosimilar) anticorps (ABIN7581284)

Antigène: CD19 (Inebilizumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Human

Clonalité: Monoclonal

Conjugué: Cet anticorp CD19 (Inebilizumab Biosimilar) est non-conjugé

Application: ELISA, Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Détail du produit anti-CD19 (Inebilizumab Biosimilar) anticorps

Expression System: CHO Cells

Fonction: Anti-CD19 Reference Antibody (inebilizumab)

Attributs du produit: Anti-CD19 Reference Antibody (inebilizumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 147.42 kDa.

Pureté: >95 %

Isotype: IgG1

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Commentaires:

Conditions: B-cell malignancies Chronic Lymphocytic Leukemia Multiple Myeloma Neuromyelitis optica spectrum disorder Scleroderma

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Stock: 4 °C,-80 °C

Stockage commentaire: +4°C,-80°C

Détails sur CD19 (Inebilizumab Biosimilar)

Antigène: CD19 (Inebilizumab Biosimilar)

Classe de substances: Biosimilar

Poids moléculaire: 147.42 kDa

UniProt: P15391